These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 18992820)
21. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease. Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753 [TBL] [Abstract][Full Text] [Related]
22. Huntington disease: new insights on the role of huntingtin cleavage. Wellington CL; Leavitt BR; Hayden MR J Neural Transm Suppl; 2000; (58):1-17. PubMed ID: 11128600 [TBL] [Abstract][Full Text] [Related]
23. Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Van Raamsdonk JM; Murphy Z; Slow EJ; Leavitt BR; Hayden MR Hum Mol Genet; 2005 Dec; 14(24):3823-35. PubMed ID: 16278236 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus. Gafni J; Hermel E; Young JE; Wellington CL; Hayden MR; Ellerby LM J Biol Chem; 2004 May; 279(19):20211-20. PubMed ID: 14981075 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of apoptosis signal-regulating kinase 1 reduces endoplasmic reticulum stress and nuclear huntingtin fragments in a mouse model of Huntington disease. Cho KJ; Lee BI; Cheon SY; Kim HW; Kim HJ; Kim GW Neuroscience; 2009 Nov; 163(4):1128-34. PubMed ID: 19646509 [TBL] [Abstract][Full Text] [Related]
26. Activation of Caspase-6 Is Promoted by a Mutant Huntingtin Fragment and Blocked by an Allosteric Inhibitor Compound. Ehrnhoefer DE; Skotte NH; Reinshagen J; Qiu X; Windshügel B; Jaishankar P; Ladha S; Petina O; Khankischpur M; Nguyen YTN; Caron NS; Razeto A; Meyer Zu Rheda M; Deng Y; Huynh KT; Wittig I; Gribbon P; Renslo AR; Geffken D; Gul S; Hayden MR Cell Chem Biol; 2019 Sep; 26(9):1295-1305.e6. PubMed ID: 31353319 [TBL] [Abstract][Full Text] [Related]
27. Selective degeneration in YAC mouse models of Huntington disease. Van Raamsdonk JM; Warby SC; Hayden MR Brain Res Bull; 2007 Apr; 72(2-3):124-31. PubMed ID: 17352936 [TBL] [Abstract][Full Text] [Related]
31. A Huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant Huntingtin-induced motor and behavioral deficits. Aharony I; Ehrnhoefer DE; Shruster A; Qiu X; Franciosi S; Hayden MR; Offen D Hum Mol Genet; 2015 May; 24(9):2604-14. PubMed ID: 25616965 [TBL] [Abstract][Full Text] [Related]
32. N-terminal proteolysis of full-length mutant huntingtin in an inducible PC12 cell model of Huntington's disease. Ratovitski T; Nakamura M; D'Ambola J; Chighladze E; Liang Y; Wang W; Graham R; Hayden MR; Borchelt DR; Hirschhorn RR; Ross CA Cell Cycle; 2007 Dec; 6(23):2970-81. PubMed ID: 18156806 [TBL] [Abstract][Full Text] [Related]
33. Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. Landles C; Sathasivam K; Weiss A; Woodman B; Moffitt H; Finkbeiner S; Sun B; Gafni J; Ellerby LM; Trottier Y; Richards WG; Osmand A; Paganetti P; Bates GP J Biol Chem; 2010 Mar; 285(12):8808-23. PubMed ID: 20086007 [TBL] [Abstract][Full Text] [Related]
34. Live cell imaging and biophotonic methods reveal two types of mutant huntingtin inclusions. Caron NS; Hung CL; Atwal RS; Truant R Hum Mol Genet; 2014 May; 23(9):2324-38. PubMed ID: 24334607 [TBL] [Abstract][Full Text] [Related]
35. Huntingtin fragmentation and increased caspase 3, 8 and 9 activities in lymphoblasts with heterozygous and homozygous Huntington's disease mutation. Maglione V; Cannella M; Gradini R; Cislaghi G; Squitieri F Mech Ageing Dev; 2006 Feb; 127(2):213-6. PubMed ID: 16289252 [TBL] [Abstract][Full Text] [Related]
36. Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease. Lecerf JM; Shirley TL; Zhu Q; Kazantsev A; Amersdorfer P; Housman DE; Messer A; Huston JS Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4764-9. PubMed ID: 11296304 [TBL] [Abstract][Full Text] [Related]
37. Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts. Sawa A; Nagata E; Sutcliffe S; Dulloor P; Cascio MB; Ozeki Y; Roy S; Ross CA; Snyder SH Neurobiol Dis; 2005 Nov; 20(2):267-74. PubMed ID: 15890517 [TBL] [Abstract][Full Text] [Related]
38. Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract. Hazeki N; Nakamura K; Goto J; Kanazawa I Biochem Biophys Res Commun; 1999 Mar; 256(2):361-6. PubMed ID: 10079189 [TBL] [Abstract][Full Text] [Related]
39. Huntington disease and the huntingtin protein. Zheng Z; Diamond MI Prog Mol Biol Transl Sci; 2012; 107():189-214. PubMed ID: 22482451 [TBL] [Abstract][Full Text] [Related]
40. Analysis of proteolytic processes and enzymatic activities in the generation of huntingtin n-terminal fragments in an HEK293 cell model. Tebbenkamp AT; Crosby KW; Siemienski ZB; Brown HH; Golde TE; Borchelt DR PLoS One; 2012; 7(12):e50750. PubMed ID: 23236391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]